Samsung Biologics has launched a $1.8 billion all-cash bid for the Swiss peptide manufacturer PolyPeptide Group. The deal, ...

Autoantibodies are central to the diagnosis, classification, and stratification of many autoimmune diseases, particularly those characterised by B-cell activation and MHC class II associations.

Pfenex platform that establishes recombinant production as a viable, sustainable, and competitive approach for large-scale ...

Learn how to verify research-grade peptide purity using HPLC, mass spectrometry, and Certificates of Analysis, plus the key ...

Learn how to overcome purification bottlenecks in modern drug discovery with advanced purification strategies, streamlined workflows, and automation.

Discover how the next generation of DMTA is creating a future-ready drug discovery engine through AI and automation.

Codexis (NASDAQ:CDXS) reported first-quarter 2026 revenue of $15.2 million, up from $7.5 million a year earlier, as the company highlighted continued progress commercializing its ECO Synthesis ...

North Augusta-based AmbioPharm has announced it will be expanding its existing manufacturing facility in Aiken County, investing $118.96 million and creating 202 new jobs in the process. AmbioPharm ...

Peptides, as essential biomolecules linking amino acids and proteins, play a vital role across numerous disciplines, including life science research, drug discovery, biomaterials engineering, and ...

The company expects 2026 revenue in the range of $72 million to $76 million, with revenue "more heavily weighted towards the second half of 2026 versus the first half." Moore asserted, "Our goals for ...

Solid-phase peptide synthesis (SPPS) is a foundational technology in applied and basic pharmaceutical sciences. While typical SPPS protocols are generally effective, the synthesis of peptides that ...